article thumbnail

Top biopharmaceutical Covid-19 vaccine companies boosted with over 80% revenue growth

Pharmaceutical Technology

The top 13 players reported more than 10% revenue growth, with BioNTech (3,834.4%), Moderna (2,199.1%), Pfizer (95.2%) and Regeneron Pharmaceuticals (89.1%) reporting a more than 80% year-on-year (YoY) revenue growth from 2020 to 2021, according to GlobalData’s Pharma Intelligence Centre Companies Database.

Sales 108
article thumbnail

Pharma’s ESG goals need to underscore push for health equity

Pharmaceutical Technology

A survey in GlobalData’s Healthcare Industry Business Confidence Report 2020 placed sustainability initiatives at the bottom of a list of the pharmaceutical sector’s main priorities. In recent years, there has been an increasing awareness of how racial disparities affect several sectors including the pharmaceutical industry.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Paving the way for anti-Abeta active immunotherapy

European Pharmaceutical Review

Yves joined AC Immune in 2020 and is now Manager, Investor Relations and Communications. He then worked as a clinical scientist for a med tech company developing spinal cord stimulation for people living with spinal cord injury. Marie Kosco-Vilbois, PhD Marie Kosco-Vilbois joined AC Immune as Chief Scientific Officer in 2019.

article thumbnail

The Traditional Pharma Model Isn’t Working – It’s Time to Evolve!

PharmaKinnex

The pharmaceutical industry of 2022 is very different from the space that we all knew in 2012, 2016, or even 2020. The Traditional Pharma Model Isn’t Working – It’s Time to Evolve! August 23, 2022. dstansberry@costellocreativegroup.com. The PhRMA Code, The Sunshine Act, & Inflation Reduction. “On

Pharma 52
article thumbnail

Innovations & Challenges in Brain Health

PM360

Greene joined Sage as CEO in 2020, bringing more than 30 years of biopharmaceutical industry experience to this position. Before Sage, he served as president of Alnylam Pharmaceuticals, Inc. Barry is a member of the board of the Pharmaceutical Research and Manufacturers of America (PhRMA). Patients are waiting!

article thumbnail

Beating the Big C

Pharmaceutical Technology

” While Pfizer is currently testing 18 medicines targeted against pancreatic, breast and lung cancers, figures released by the Pharmaceutical Research and Manufacturers of America [PhRMA] in April 2008 reveal that research companies are currently testing a record-breaking 750 experimental cancer drugs in America alone. .”

article thumbnail

PhRMA is going to have to write some big checks

World of DTC Marketing

The Pharmaceutical Research and Manufacturers of America raised nearly $527 million last year and spent roughly $506 million, new tax returns obtained by OpenSecrets reveal. That’s a record haul for the organization, which is funded by the world’s most powerful pharmaceutical companies. Leading lobbying industries in the U.S.